$5.47
0.09[1.67%]
At close: Apr 25
$5.47
0[0.00%]
After Hours: 6:35PM EDT
Lantern Pharma
(NASDAQ:LTRN)Lantern Pharma Stock (NASDAQ:LTRN), Analyst Ratings, Price Targets, Predictions
Lantern Pharma Inc has a consensus price target of $3.67, established from looking at the 11 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., EF Hutton, and EF Hutton on April 25, 2024, August 10, 2023, and June 26, 2023. With an average price target of $7.33 between HC Wainwright & Co., EF Hutton, and EF Hutton, there's an implied 34.06% upside for Lantern Pharma Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
EF Hutton
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Lantern Pharma
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/25/2024 | LTRN | Buy Now | Lantern Pharma | $5.47 | — | HC Wainwright & Co. | Emily Bodnar | — | Reiterates | → Neutral | Get Alert |
| 08/10/2023 | LTRN | Buy Now | Lantern Pharma | $5.47 | 101.1% | EF Hutton | Michael King | → $11 | Reiterates | Buy → Buy | Get Alert |
| 06/26/2023 | LTRN | Buy Now | Lantern Pharma | $5.47 | 101.1% | EF Hutton | Michael King | $11 → $11 | Maintains | Buy | Get Alert |
| 05/25/2023 | LTRN | Buy Now | Lantern Pharma | $5.47 | 101.1% | EF Hutton | Michael King | → $11 | Assumes | → Buy | Get Alert |
| 05/18/2023 | LTRN | Buy Now | Lantern Pharma | $5.47 | — | HC Wainwright & Co. | Michael King | — | Initiates | → Neutral | Get Alert |
| 03/21/2023 | LTRN | Buy Now | Lantern Pharma | $5.47 | 101.1% | EF Hutton | Michael King | → $11 | Reiterates | → Buy | Get Alert |
| 02/15/2023 | LTRN | Buy Now | Lantern Pharma | $5.47 | 101.1% | EF Hutton | Michael King | → $11 | Maintains | Buy | Get Alert |
| 11/01/2022 | LTRN | Buy Now | Lantern Pharma | $5.47 | 101.1% | EF Hutton | Michael King | → $11 | Initiates | → Buy | Get Alert |
| 03/11/2022 | LTRN | Buy Now | Lantern Pharma | $5.47 | 558.14% | HC Wainwright & Co. | Michael King | $34 → $36 | Maintains | Buy | Get Alert |
| 11/02/2021 | LTRN | Buy Now | Lantern Pharma | $5.47 | 521.57% | HC Wainwright & Co. | Michael King | — | Maintains | Buy | Get Alert |
| 10/07/2021 | LTRN | Buy Now | Lantern Pharma | $5.47 | 485.01% | HC Wainwright & Co. | Michael King | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Lantern Pharma (LTRN)?
The latest price target for Lantern Pharma (NASDAQ: LTRN) was reported by HC Wainwright & Co. on April 25, 2024. The analyst firm set a price target for $0.00 expecting LTRN to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lantern Pharma (LTRN)?
The latest analyst rating for Lantern Pharma (NASDAQ: LTRN) was provided by HC Wainwright & Co., and Lantern Pharma reiterated their neutral rating.
When was the last upgrade for Lantern Pharma (LTRN)?
There is no last upgrade for Lantern Pharma.
When was the last downgrade for Lantern Pharma (LTRN)?
There is no last downgrade for Lantern Pharma.
When is the next analyst rating going to be posted or updated for Lantern Pharma (LTRN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lantern Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lantern Pharma was filed on April 25, 2024 so you should expect the next rating to be made available sometime around April 25, 2025.
Is the Analyst Rating Lantern Pharma (LTRN) correct?
While ratings are subjective and will change, the latest Lantern Pharma (LTRN) rating was a reiterated with a price target of $0.00 to $0.00. The current price Lantern Pharma (LTRN) is trading at is $5.47, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.